| Dr Victoria Ester Graham, DMD | |
|
401 S Gloster St, Suite 101, Tupelo, MS 38801-5540 | |
| (662) 269-4025 | |
| Not Available |
| Full Name | Dr Victoria Ester Graham |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 401 S Gloster St, Tupelo, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174965982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 3719-13 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victoria Ester Graham, DMD 1090 Northchase Pkwy Se, Suite 290, Marietta, GA 30067-6405 Ph: (678) 904-5665 | Dr Victoria Ester Graham, DMD 401 S Gloster St, Suite 101, Tupelo, MS 38801-5540 Ph: (662) 269-4025 |
News Archive
Mylan Laboratories has announced that the U.S. Food and Drug Administration (FDA) has confirmed Mylan's current status as the only approved ANDA for all strengths of Amlodipine Besylate Tablets.
Lorus Therapeutics Inc. today announced the start of a development program aimed at expanding the therapeutic application of its lead clinical-stage drug LOR-2040 for the treatment of superficial bladder cancer.
A combination of cisplatin and 5-fluorouracil is an effective and well-tolerated regimen for patients with squamous cell carcinoma of the penis, show study findings.
A child who suffers a moderate or severe traumatic brain injury (TBI) may still have substantial functional disabilities and reduced quality of life 2 years after the injury. After those first 2 years, further improvement may be minimal. Better interventions are needed to prevent long-lasting consequences of TBI in children conclude the authors of a study published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
YM BioSciences Inc., announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is in non-small-cell lung cancer (NSCLC) patients who are ineligible for curative treatment and being treated palliatively and the other in patients with brain metastases from NSCLC. Current NSCLC palliative treatment and treatment for brain metastases is radiation alone.
› Verified 2 days ago
Dr. Rebecca Smith Mcdougald, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1906 N Gloster St, Tupelo, MS 38804 Phone: 662-844-6420 Fax: 662-844-6421 | |
Dr. Kenneth Lee Austin, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3694 W Jackson St, Tupelo, MS 38801 Phone: 662-842-8035 Fax: 662-842-3018 | |
Dr. Carley Cole Wall, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 901 Garfield St, Tupelo, MS 38801 Phone: 662-844-6464 | |
Dr. James Keaton Lang, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1763 Cliff Gookin Blvd, Tupelo, MS 38801 Phone: 662-842-2802 | |
Ms. Shamina Khanum, DENTIST Dentist Medicare: Medicare Enrolled Practice Location: 401 S Gloster St Ste 101, Sunnybrook Dentistry, Tupelo, MS 38801 Phone: 662-346-5906 Fax: 678-247-7874 | |
Dr. Dennis Davis Bond Sr., D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 499 Gloster Creek Vlg Ste F5a, Suite F-5a, Tupelo, MS 38801 Phone: 662-844-9580 | |
Dr. John Kevin Holman, DMD MSD Dentist Medicare: Not Enrolled in Medicare Practice Location: 99 Park Gate Dr, Tupelo, MS 38801 Phone: 662-842-1735 Fax: 662-842-1769 |